Optimizing age-specific vaccination

Meagan C Fitzpatrick^{1

2}, Alison P Galvani³

Affiliations

¹ Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
² Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA.
³ Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA. alison.galvani@yale.edu.

Comment

Meagan C Fitzpatrick et al. Science. 2021.

. 2021 Feb 26;371(6532):890-891.

doi: 10.1126/science.abg2334. Epub 2021 Jan 21.

Meagan C Fitzpatrick^{1

2}, Alison P Galvani³

¹ Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
² Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA.
³ Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA. alison.galvani@yale.edu.

No abstract available

Comment on

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.
Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, Larremore DB. Bubar KM, et al. Science. 2021 Feb 26;371(6532):916-921. doi: 10.1126/science.abe6959. Epub 2021 Jan 21. Science. 2021. PMID: 33479118 Free PMC article.